Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 3, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Multiple MyelomaNon-hodgkin LymphomaHodgkin Lymphoma

Interventions

DRUG

Filgrastim Prefilled Syringe [Zarzio®]

Daily subcutaneous injection of Zarxio post ASCT, from day 5 until bone marrow recovery (neutrophils \>1 giga/l)

All Listed Sponsors

lead

University Hospital, Brest

OTHER

NCT03323541 - Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure | Biotech Hunter | Biotech Hunter